Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

被引:0
|
作者
Mathieu Claireaux
Rémy Robinot
Jérôme Kervevan
Mandar Patgaonkar
Isabelle Staropoli
Anne Brelot
Alexandre Nouël
Stacy Gellenoncourt
Xian Tang
Mélanie Héry
Stevenn Volant
Emeline Perthame
Véronique Avettand-Fenoël
Julian Buchrieser
Thomas Cokelaer
Christiane Bouchier
Laurence Ma
Faroudy Boufassa
Samia Hendou
Valentina Libri
Milena Hasan
David Zucman
Pierre de Truchis
Olivier Schwartz
Olivier Lambotte
Lisa A. Chakrabarti
机构
[1] Université de Paris,Virus and Immunity Unit, Institut Pasteur
[2] CNRS UMR3569,Bioinformatics and Biostatistics Hub, Department of Computational Biology, Institut Pasteur
[3] Université de Paris,AP
[4] Laboratoire de Microbiologie clinique,HP Hôpital Necker
[5] Université Paris Descartes,Enfants Malades
[6] Sorbonne Paris Cité,CNRS 8104, INSERM U1016
[7] Faculté de Médecine,Biomics Platform, C2RT, Institut Pasteur
[8] Université de Paris,Cytometry and Biomarkers (CB UTechS), Translational Research Center, Institut Pasteur
[9] INSERM U1018,AP
[10] Center for Research in Epidemiology and Population Health (CESP),HP, Infectious and Tropical Diseases Department
[11] Université de Paris,AP
[12] HIV Unit,HP, Department of Internal Medicine and Clinical Immunology
[13] Foch Hospital,undefined
[14] Raymond Poincaré Hospital,undefined
[15] INSERM U1184,undefined
[16] Université Paris Sud,undefined
[17] CEA,undefined
[18] Center for Immunology of Viral Infections and Autoimmune Diseases,undefined
[19] University Hospital Paris Sud,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-specific CD4 + T cells reveals an advanced Th1 differentiation pattern in controllers, except for the CCR5 marker, which is downregulated compared to specific cells of treated patients. Accordingly, controller specific CD4 + T cells show decreased susceptibility to CCR5-dependent HIV entry. Two controllers carried biallelic mutations impairing CCR5 surface expression, indicating that in rare cases CCR5 downregulation can have a direct genetic cause. Increased expression of β-chemokine ligands upon high-avidity antigen/TCR interactions contributes to autocrine CCR5 downregulation in controllers without CCR5 mutations. These findings suggest that genetic and functional regulation of the primary HIV coreceptor CCR5 play a key role in promoting natural HIV control.
引用
收藏
相关论文
共 50 条
  • [21] Deconstructing HIV-Specific CD8+T Cell Responses in HIV Elite Controllers
    Ndhlovu, Z. M.
    Chibnik, L. B.
    Proundfoot, J.
    Vine, S.
    Porichis, F.
    McMullen, A.
    Cesa, K.
    Piechocka-Trocha, A.
    De Jager, P. L.
    Kaufmann, D. E.
    Walker, B. D.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A13 - A13
  • [22] Decreased CCR5 expression on CD4+ T cells of SIV-infected sooty Mangabeys
    Veazey, R
    Ling, BH
    Pandrea, I
    McClure, H
    Lackner, A
    Marx, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (03) : 227 - 233
  • [23] CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication
    Tebas, Pablo
    Jadlowsky, Julie K.
    Shaw, Pamela A.
    Tian, Lifeng
    Esparza, Erin
    Brennan, Andrea L.
    Kim, Sukyung
    Naing, Soe Yu
    Richardson, Max W.
    Vogel, Ashley N.
    Maldini, Colby R.
    Kong, Hong
    Liu, Xiaojun
    Lacey, Simon F.
    Bauer, Anya M.
    Mampe, Felicity
    Richman, Lee P.
    Lee, Gary
    Ando, Dale
    Levine, Bruce L.
    Porter, David L.
    Zhao, Yangbing
    Siegel, Don L.
    Bar, Katharine J.
    June, Carl H.
    Riley, James L.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (07):
  • [24] HIV-specific CD4+ T cells and viremia:: who's in control?
    Jansen, CA
    van Baarle, D
    Miedema, F
    TRENDS IN IMMUNOLOGY, 2006, 27 (03) : 119 - 124
  • [25] Diminished CD4+ T cell surface CCR5 expression in alcoholic patients
    Perney, P
    Portalès, P
    Clot, J
    Blanc, F
    Corbeau, P
    ALCOHOL AND ALCOHOLISM, 2004, 39 (06): : 484 - 485
  • [26] Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
    Didigu, Chuka A.
    Wilen, Craig B.
    Wang, Jianbin
    Duong, Jennifer
    Secreto, Anthony J.
    Danet-Desnoyers, Gwenn A.
    Riley, James L.
    Gregory, Phillip D.
    June, Carl H.
    Holmes, Michael C.
    Doms, Robert W.
    BLOOD, 2014, 123 (01) : 61 - 69
  • [27] HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells
    Pfaff, Jennifer M.
    Wilen, Craig B.
    Harrison, Jessamina E.
    Demarest, James F.
    Lee, Benhur
    Doms, Robert W.
    Tilton, John C.
    JOURNAL OF VIROLOGY, 2010, 84 (13) : 6505 - 6514
  • [28] Glucocorticoid-induced tumor necrosis factor receptor family-related protein triggering enhances HIV-specific CD4+ T cell cytokine secretion and protects HIV-specific CD4+ T cells from apoptosis
    Lahey, Timothy P.
    Loisel, Suzanne D.
    Wieland-Alter, Wendy
    JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (01): : 43 - 49
  • [29] Distribution and phenotype of HIV-specific CD8 T cells in situ in the rectal mucosa of HIV elite controllers
    Li, Shengbin
    Kovacs, Katalin
    Kiniry, Brenna
    Wagstaff, Reece
    April, Ferre
    Hunt, Peter
    Somsouk, Ma
    Shacklett, Barbara L.
    Skinner, Pamela J.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [30] Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood
    Mo, HM
    Monard, S
    Pollack, H
    Ip, J
    Rochford, G
    Wu, LJ
    Hoxie, J
    Borkowsky, W
    Ho, DD
    Moore, JP
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (07) : 607 - 617